Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease

  1. Eric P. Meyer*,
  2. Alexandra Ulmann-Schuler*,
  3. Matthias Staufenbiel, and
  4. Thomas Krucker,§
  1. *Department of Zoology, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland;
  2. Novartis Institutes for BioMedical Research, Inc., Discovery Technologies, Cambridge, MA 02139; and
  3. Novartis Institutes for BioMedical Research Basel, Nervous System Research, CH-4002 Basel, Switzerland
  1. Edited by Floyd E. Bloom, The Scripps Research Institute, La Jolla, CA, and approved January 14, 2008 (received for review October 15, 2007)

Abstract

Substantial evidence from epidemiological, pathological, and clinical reports suggests that vascular factors are critical in the pathogenesis of Alzheimer's disease (AD), and changes in blood flow are currently the most reliable indicators of the disease. We previously reported that older APP23 transgenic (tg) mice have significant blood flow alterations correlated with structural modifications of blood vessels. For the present study, our objective was to analyze the age-dependent morphological and architectural changes of the cerebral vasculature of APP23 tg mice. To visualize the 3D arrangement of the entire brain vasculature, we used vascular corrosion casts. Already at young ages, when typically parenchymal amyloid plaques are not yet present, APP23 tg mice had significant alterations, particularly of the microvasculature, often accompanied by small deposits attached to the vessels. In older animals, vasculature abruptly ended at amyloid plaques, resulting in holes. Often, small deposits were sitting near or at the end of truncated vessels. Between such holes, the surrounding vascular array appeared more dense and showed features typical for angiogenesis. We propose that small amyloid aggregates associated with the microvasculature lead to morphological and architectural alterations of the vasculature, resulting in altered local blood flow. The characteristic early onset of vascular alterations suggests that imaging blood flow and/or vasculature architecture could be used as a tool for early diagnosis of the disease and to monitor therapies.

Footnotes

  • §To whom correspondence should be addressed. E-mail: thomas.krucker{at}novartis.com
  • Author contributions: E.P.M. and A.U.-S. contributed equally to this work; E.P.M., A.U.-S., and T.K. designed research; E.P.M., A.U.-S., and T.K. performed research; E.P.M. and T.K. contributed new reagents/analytic tools; E.P.M., A.U.-S., and T.K. analyzed data; and E.P.M., A.U.-S., M.S., and T.K. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0709788105/DC1.

  • Freely available online through the PNAS open access option.

« Previous | Next Article »Table of Contents
OPEN ACCESS ARTICLE